CD8+ T Cells Clear Influenza Virus by Perform or Fas-Dependent Processes

Journal of Immunology

Volumn 159, Issue 11, 1997, Pages 5197-5200

  Topham, David J ^a   Tripp, Ralph A ^b   Doherty, Peter C ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; MEMBRANE PROTEIN; PERFORIN; PORE FORMING CYTOTOXIC PROTEIN;

ANIMAL; ARTICLE; C57BL MOUSE; CD8+ T LYMPHOCYTE; IMMUNOLOGY; INFLUENZA VIRUS A; MOUSE; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; ORTHOMYXOVIRUS INFECTION; RADIATION CHIMERA;

ANIMALS; ANTIGENS, CD95; CD8-POSITIVE T-LYMPHOCYTES; INFLUENZA A VIRUS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; ORTHOMYXOVIRIDAE INFECTIONS; PORE FORMING CYTOTOXIC PROTEINS; RADIATION CHIMERA;

EID: 0031307852     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Doherty, P. C. 1996. Cytotoxic T cell effector and memory function in viral immunity. Curr. Top. Microbiol. Immunol. 206:1.
2. + T cells promote the clearance of influenza virus from major histocompatibility complex class II -/-respiratory epithelium. J. Virol. 70: 1288.
3. Palladino, G., K. Mozdzanowska, G. Washko, and W. Gerhard. 1995. Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J. Virol. 69:2075.
4. ++ T cell depletion. Reg. Immunol. 5:142.
5. + T cells requires direct targeting to virus-infected epithelium. Eur. J. Immunol. 25:111.
6. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
7. Walsh, C. M., M. Matloubian, C.-C. Liu, R. Ueda, C. G. Kurahara, J. L. Christensen, M. T. F. Huang, J. D.-E. Young, R. Ahmed, and W. R. Clark. 1994. Immune function in mice lacking the perform gene. Proc. Natl. Acad. Sci. USA 91:10854.
8. Kägi, D., P. Seiler, J. Pavlovic, B. Ledermann, K. Bürki, R. M. Zinkernagel, and H. Hengartner. 1995. The roles of perform- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur. J. Immunol. 25: 3256.
9. + T-cell immunity to murine rotavirus in the absence of perform, fas, and γ-interferon. J. Virol. 71:479.
10. Usherwood, E. J., J. W. Brooks, S. R. Sarawar, R. D. Cardin, W. D. Young, D. J. Allen, P. C. Doherty, and A. A. Nash. Immunological control of murine γ-herpesvirus infection is independent of perform. 1997. J. Gen. Virol. 78:2025.
11. Kagi, D., and H. Hengartner. 1996. Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. Curr. Opin. Immunol. 8:473.
12. Ramsay, A. J., J. Ruby, and I. A. Ramshaw. 1993. A case for cytokines as effector molecules in the resolution of virus infection. Immunol. Today 14:155.
13. Guidotti, L. G., P. Borrow, M. V. Hobbs, B. Matzke, I. Gresser, M. B. A. Oldstone, and F. V. Chisari. 1996. Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc. Natl. Acad. Sci. USA 93:4589.
14. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perform and Fas lytic pathways. Nature 370: 650.
15. 2+ T cells. J. Immunol. 144:3980.
16. Mariani, S. M., B. Matiba, E. A. Armandola, and P. H. Krammer. 1994. The APO-1/Fas (CD95) receptor is expressed in homozygous MRL/lpr mice. Eur. J. Immunol. 24:3119.
17. + memory T cells. J. Immunol. 154:5870.
18. Takizawa, T., R. Fukuda, T. Miyawaki, K. Ohashi, and Y. Nakanishi. 1995. Activation of the apoptotic Fas antigen-encoding gene upon influenza virus infection involving spontaneously produced beta-interferon. Virology 209:288.
19. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169.
20. Chinniayan, A. M., and V. M. Dixit. 1997. Portrait of an executioner: the molecular mechanism of Fas/APO-1-induced apoptosis. Semin. Immunol. 9:69.
21. Zhivotovsky, B., D. H. Burgess, D. M. Vanags, and S. Orrenius. 1997. Involvement of cellular proteolytic machinery in apoptosis. Biochem. Biophys. Res. Commun. 230:481.
22. Darmon, A. J., D. W. Nicholson, and R. C. Bleackley. 1995. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 377: 446.
23. Komatsu, T., Z. Bi, and C. S. Reiss. 1996. Interferon-γ induced type I nitric oxide synthase activity inhibits viral replication in neurons. J. Neuroimmunol. 68:101.
24. Ando, K., K. Hiroishi, T. Kaneko, T. Moriyama, Y. Muto, N. Kayagaki, H. Yagita, K. Okumura, and M. Imawari. 1997. Perform, Fas/Fas ligand, and TNF-α pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J. Immunol. 158:5283.
25. Lukacher, A. E., V. L. Braciale, and T. J. Braciale. 1984. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J. Exp. Med. 160:814.